be associated with immune complex formation in the acute phase of illness, or it may represent a pre-existing abnormality that predisposes to the development of arthritis. It is also conceivable that the expression of arthritis is influenced by the major HLA antigens: an increased frequency of HIA-DR4 and absence of DRI in HPV arthritis has been reported previously,7 and an association with HLA-B27 has also been suggested.8 The aim of this study was to determine the effect of HIA antigens and hypocomplementaemia on the severity and persistence of joint involvement in HPV infection.
Objectives-To determine the effect of HLA type and hypocomplementaemia on the duration and severity of joint involvement in parvovirus infection (HPV). Methods-Forty seven patients were selected on a geographical basis from 83 with proven HPV infection during an outbreak that occurred in Oxfordshire in 1993. They were contacted by questionnaire a year later. Thirty five patients were available for examination and blood sampling. Subjects concentration < 50 mg/l (NV 150-500 mg/l); DNA binding was increased, anticardiolipin antibody (IgG) was 15 U/ml (NV 0-10 U/ml), and the patient had a rheumatoid factor titre of 80 and an ANA titre of 40. The second patient had a C3 concentration of 590 mg/l, C4 of 60 mg/l and a rheumatoid factor titre of 80. These immunological abnormalities had all resolved by six months, except the decreased C4 concentration in the first patient, which persisted up to one year of follow up.
Examination of the records of the virology department in Oxford revealed that there were 83 positive cases (high titre of IgM antibody to B 1 9-HPV by radioimmunoassay) during January to June 1993. Most of the patients were referred for the test by their general practitioners. One year later, 55 of these subjects were selected on a geographical basis and approached through a questionnaire (three patients who had fetal loss as a result of HPV infection were excluded). Of these, 45 patients responded. Among the total of 47 patients (including the two index cases), 43 were women. The age range was 21-55 years (mean 37). Thirty five of the group agreed to undergo further assessment, examination and blood sampling.
HIA-DRB 1 alleles were typed using sequence specific oligonucleotide probes (SSOP) and polymerase chain reaction (PCR) amplification of genomic DNA as described previously.9 PCR combined with HLA-B27 SSOP were used to define the presence or absence of this allele as also described previously.'0 C3 and C4 complement concentrations were measured by nephelometry (Array nephelometer, High Wycombe, UK). A latex slide agglutination test (Hoechest, Hounslow, UK) was used to screen for IgM rheumatoid factor and, if positive, the titre was determined by the rheumatoid arthritis precipitin assay (RAPA) gel bead agglutination assay (Fujirebio Inc, Mast Diagnostics, Bootle, UK). ANA was determined by indirect immunofluorescence on young rat liver, using IgG conjugate (Incstar, Wokingham, UK).
Patients were grouped according to the duration of symptoms. The limits of one week, two months, and until review were chosen arbitrarily to define short, medium, and prolonged duration of symptoms.
STATISTICAL ANALYSIS
Fisher's exact test was used to assess the significance of differences between groups. and seven described generalised swelling of the extremities, with temporary weight gain documented by one patient. The HLA-DR frequencies in patients were similar to those in controls (table) . There was a statistically significant relation between HIA-DR4 and symptom persistence beyond one week (p = 0009), but not beyond two months (p = 0-06). There was no relation between the HLA type and the severity of symptoms as determined by the number of ARA criteria satisfied, or by a general estimate by the researcher. HLA-B27 was positive in two patients; one of them had back pain that predated her HPV infection.
Results
At one year, C4 concentration was decreased in four patients (HLA types: DR3/DR3, DR3/DR5 and DR4/DR2 in two patients), but C3 was normal in all. There was no correlation between hypocomplementaemia and persistence or severity of joint symptoms. Rheumatoid factor was positive with a titre of 160 in one patient and 80 in another. Both these patients had joint symptoms persisting until review and, respectively, would have satisfied 5 and 4 of the 1987 ARA criteria applied retrospectively; however, they did not fulfill the criteria for RA when examined at one year. An ANA titre of 40 was present in two patients.
Discussion
There has been an interest in HPV as a possible infectious trigger for RA. Joint symptoms in the form of pain, stiffness, and swelling can persist, and the ARA criteria for RA may be transiently satisfied. However, follow up studies, including ours, have generally failed to demonstrate progression to an erosive deforming arthritis. ' Such progression, when it has occasionally been described,2 3 was probably coincidental. It is possible that HPV infection may lead to RA many years after the original infection. However, the results of studies attempting to link RA to previous HPV exposure are conflicting.2 12 13 Three of our patients developed carpal tunnel syndrome. This is consistent with the reported association of HPV with finger paraesthesia and slowing of nerve conduction velocities. 14 whole. This could be explained by differences between the studies regarding patient recruitment, as ours were referred by general practitioners for serological testing, in contrast with direct referral to an early synovitis clinic.7 15 Although we selected patients from the cohort on a geographical basis, some bias towards severity could have occurred at the levels of general practitioner referrals and patient responses to the questionnaire. However, our study does suggest a weak effect of HLA-DR4 on the persistence of joint symptoms. The frequency of HLA-DR4 was 48% in those whose symptoms persisted beyond one week, but was completely absent in those whose symptoms resolved within one week. Although there is documented association of severity of RA with certain genotypes (for example Dw4/Dwl4), the numbers in our study were too small to find a similar relation in HPV arthritis. We could not confirm the reported absence of HLA-DR1,7 15 or the suggested relation with HLA-B27. 8 Immunological abnormalities are known to occur in HPV infection,' 4 but we found that such abnormalities persisted only in a minority at one year. The persistence of decreased concentrations of C4 in four of our patients suggests a pre-existing abnormality that was accentuated during the acute illness in one of our patients; however, the number of patients with decreased C4 was too small to permit us to draw any conclusions. To define the exact relation of hypocomplementaemia to the pathogenesis of HPV arthritis, it may be helpful to study the profile of complement levels throughout the illness, combined with typing for complement null alleles. 
